HPS Pharmacies wish to give notice that Boehringer Ingelheim has announced the discontinuation of Asasantin® SR and Persantin® SR capsules as follows:
Asasantin® SR Capsules
Dipyridamole + Aspirin 200mg/25mg
Persantin® SR Capsules
Supply of Asasantin® SR and Persantin® SR capsules to wholesalers will cease from June 30 2020. Please note that this notice does not apply to Persantin® ampoules. Persantin® ampoules will continue to be available as an alternative to exercise in myocardial imaging.
Diasp® SR (dipyridamole + aspirin) capsules are an alternative to Asasantin® SR capsules. However, Diasp® SR is currently unavailable; normal supplies are expected to return in late 2020.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Boehringer Ingelheim on (02) 8875 8800 or your pharmacist at HPS Pharmacies.